SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 141 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q2 2018. The put-call ratio across all filers is 1.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $82,000 | -18.0% | 45,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $100,000 | -23.7% | 45,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $131,000 | -34.5% | 45,000 | 0.0% | 0.00% | -50.0% |
| Q2 2017 | $200,000 | -14.2% | 45,000 | -10.0% | 0.00% | 0.0% |
| Q1 2017 | $233,000 | -23.6% | 50,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $305,000 | +38.6% | 50,000 | +25.0% | 0.00% | 0.0% |
| Q3 2016 | $220,000 | +44.7% | 40,000 | 0.0% | 0.00% | +100.0% |
| Q2 2016 | $152,000 | – | 40,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 7,590,000 | $28,842,000 | 8.26% |
| Asymmetry Capital Management, L.P. | 298,190 | $1,133,000 | 2.08% |
| ARMISTICE CAPITAL, LLC | 1,330,000 | $5,054,000 | 1.92% |
| Belmont Global Advisors, Inc. | 385,000 | $1,463,000 | 1.40% |
| Paulson & Co. | 27,756,668 | $105,475,000 | 1.07% |
| Trellus Management Company, LLC | 162,900 | $619,000 | 1.01% |
| DAFNA Capital Management LLC | 319,563 | $1,214,000 | 0.96% |
| PURA VIDA INVESTMENTS, LLC | 350,000 | $1,330,000 | 0.56% |
| WALL STREET ASSOCIATES | 269,300 | $1,023,000 | 0.41% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,603,334 | $6,093,000 | 0.34% |